Guidelines for the use of contrast-enhanced ultrasound in hepatocellular carcinoma

European Journal of Cancer, Supplement

Volumn 6, Issue 11, 2008, Pages 1-8

  Lencioni, Riccardo ^a   Della Pina, Clotilde ^a   Cioni, Dania ^a   Crocetti, Laura ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Computed tomography; Contrast agent; Hepatocellular carcinoma; Liver cirrhosis; Magnetic resonance imaging; Ultrasound

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CONTRAST ENHANCEMENT; HUMAN; LIVER CELL CARCINOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; ULTRASOUND;

EID: 49049102053     PISSN: 13596349     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcsup.2008.06.002     Document Type: Article

References (58)

1. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the study of the liver. J Hepatol 2001;35:421-30.
2. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
3. Lencioni R., Cioni D., and Bartolozzi C. Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol 12 (2002) 151-165
4. BCLC Group. Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma. Eur Radiol 2006;16:2454-62.
5. Lencioni R., Piscaglia F., and Bolondi L. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol 48 (2008) 848-857
6. EFSUMB Study Group. Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 2004;25:249-56.
7. Lencioni R., Cioni D., Crocetti L., et al. Ultrasound imaging of focal liver lesions with a second-generation contrast agent. Acad Radiol 9 Suppl. 2 (2002) S371-S374
8. Piscaglia F., Bolondi L., and Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32 (2006) 1369-1375
9. Lencioni R., Cioni D., Crocetti L., Della Pina M.C., and Bartolozzi C. Magnetic resonance imaging of liver tumors. J Hepatol 40 (2004) 162-171
10. Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 39 (2003) 1076-1084
11. Colombo M. Screening. Hepatol Res 37 Suppl. 2 (2007) S146-S151
12. Colombo M., de Franchis R., Del Ninno E., et al. Hepatocellular carcinoma in Italian patients with cirrhosis. New Engl J Med 325 (1991) 675-680
13. Yuen M.F., Cheng C.C., Lauder I.J., Lam S.K., Ooi C.G., and Lai C.L. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 31 (2000) 330-335
14. Bolondi L., Sofia S., Siringo S., Gaiani S., et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 48 (2001) 251-259
15. Trevisani F., De N.S., Rapaccini G., et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 97 (2002) 734-744
16. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983-93.
17. Kojiro M., and Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 25 (2005) 133-142
18. Caturelli E., Pompili M., Bartolucci F., et al. Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients. Radiology 220 (2001) 337-342
19. Ueda K., Terada T., Nakanuma Y., and Matsui O. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. Hum Pathol 23 (1992) 619-626
20. Kimura H., Nakajima T., Kagawa K., et al. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver 18 (1998) 14-19
21. Roncalli M., Roz E., Coggi G., et al. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 30 (1999) 1174-1178
22. Matsui O., Kadoya M., Kameyama T., et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 178 (1991) 493-497
23. Lencioni R., Cioni D., Della Pina C., Crocetti L., and Bartolozzi C. Imaging diagnosis. Semin Liver Dis 25 (2005) 162-170
24. Lencioni R., Pinto F., Armillotta N., and Bartolozzi C. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Radiology 201 (1996) 353-358
25. Gaiani S., Casali A., Serra C., et al. Assessment of vascular patterns of small liver mass lesions: value and limitation of the different Doppler ultrasound modalities. Am J Gastroenterol 95 (2000) 3537-3546
26. Gaiani S., Volpe L., Piscaglia F., and Bolondi L. Vascularity of liver tumours and recent advances in Doppler ultrasound. J Hepatol 34 (2001) 474-482
27. Fracanzani A.L., Burdick L., Borzio M., et al. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology 34 (2001) 1109-1112
28. Lencioni R., Mascalchi M., Caramella D., and Bartolozzi C. Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging. Abdom Imaging 21 (1996) 41-48
29. Teefey S.A., Hildeboldt C.C., Dehdashti F., et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology 226 (2003) 533-542
30. Isozaki T., Numata K., Kiba T., et al. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 229 (2003) 798-805
31. Quaia E., Calliada F., Bertolotto M., et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232 (2004) 420-430
32. Chen M.H., Dai Y., Yan K., et al. The role of contrast-enhanced ultrasound on the diagnosis of small hepatocellular carcinoma (
33. Xu H.X., Liu G.J., Lu M.D., et al. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 34 (2006) 261-272
34. Gaiani S., Celli N., Piscaglia F., et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 41 (2004) 421-426
35. Bolondi L., Gaiani S., Celli N., et al. Characterization of small nodules in cirrhosis by assessment of vascularity : the problem of hypovascular hepatocellular carcinoma. Hepatology 42 (2005) 27-34
36. Forner A., Vilana R., Ayuso C., et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47 (2007) 97-104
37. Valls C., Cos M., Figueras J., et al. Pre-transplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT. AJR Am J Roentgenol. 182 (2004) 1011-1017
38. Marrero J.A., Hussain H.K., Nghiem H.V., Umar R., Fontana R.J., and Lok A.S. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 11 (2005) 281-289
39. Kim T., Federle M.P., Baron R.L., Peterson M.S., and Kawamori Y. Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology 219 (2001) 699-706
40. Dai Y., Chen M.H., Fan Z.H., Yan K., Yin S.S., and Zhang X.P. Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis: comparison between contrast-enhanced ultrasound and contrast-enhanced helical computed tomography. Hepatol Res 38 (2008) 281-290
41. Nicolau C., Catala V., Vilana R., et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 14 (2004) 1092-1099
42. Liu G.J., Xu H.X., Lu M.D., et al. Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology. Br J Radiol 80 (2007) 321-330
43. Jang H.J., Kim T.K., Burns P., and Wilson S.R. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 244 (2007) 898-906
44. Bennett G.L., Krinsky G.A., Abitbol R.J., Kim S.Y., Theise N.D., and Teperman L.W. Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol 179 (2002) 75-80
45. Liu W.C., Lim J.H., Park C.K., et al. Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pre-transplantation sonography in 118 patients. Eur Radiol 13 (2003) 1693-1698
46. Burrel M., Llovet J.M., Ayuso C., et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 38 (2003) 1034-1042
47. Gaiani S., Bolondi L., Li Bassi S., et al. Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology 100 (1991) 160-167
48. Llovet J.M., Bru C., and Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19 (1999) 329-338
49. Tarantino L., Francica G., Sordelli I., et al. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging 31 (2006) 537-544
50. Piscaglia F., Gianstefani A., Ravaioli M., et al. Ultraschall Med 28 Supplement (2007) S35
51. Kojiro M. Diagnostic discrepancy of early hepatocellular carcinoma between Japan and West. Hepatol Res 37 Suppl. 2 (2007) S121-S124
52. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
53. Bartolozzi C., Crocetti L., Lencioni R., Cioni D., Della Pina C., and Campani D. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 17 (2007) 2519-2530
54. Llovet J.M., Chen Y., Wurmbach E., et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 131 (2006) 1758-1767
55. Lencioni R., Allgaier H.P., Cioni D., et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 228 (2003) 235-240
56. Lin S.M., Lin C.J., Lin C.C., et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 127 (2004) 1714-1723
57. Shiina S., Teratani T., Obi S., et al. A randomized controlled trial of radiofrequency ablation versus ethanol injection for small hepatocellular carcinoma. Gastroenterology 129 (2005) 122-130
58. Lencioni R., Cioni D., Crocetti L., et al. Early-stage hepatocellular carcinoma in cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234 (2005) 961-967